ライフサイエンスコーパス: sexual function

1 scular disease, and altered reproductive and sexual function).

2 clinics, use of emergency contraception, and sexual function).

3 fat; and both contributed to the decline in sexual function.

4 asing the probability and speed of return of sexual function.

5 ported having a moderate or big problem with sexual function.

6 receptors on GRP neurons and facilitate male sexual function.

7 or radiation results in permanent changes in sexual function.

8 aging in males may contribute to the loss of sexual function.

9 emotional, and functional domains as well as sexual function.

10 rative strategies for better preservation of sexual function.

11 Cryotherapy greatly reduces sexual function.

12 Ejaculation is an integral part of normal sexual function.

13 initial worsening of urinary continence and sexual function.

14 sts information about strategies to optimize sexual function.

15 d using medication or supplements to improve sexual function.

16 d by 2 mm margins that allow preservation of sexual function.

17 although the tamoxifen group reported better sexual function.

18 ht and energy homeostasis, inflammation, and sexual function.

19 reatment options for symptomatic LUTS/BPH on sexual function.

20 ssess the effect of BPH and its treatment on sexual function.

21 Some treatments for BPH can affect sexual function.

22 and pretreatment symptom status, especially sexual function.

23 each class of drug having a unique affect on sexual function.

24 be fully informed of the potential risks to sexual function.

25 metabolic syndrome, and decreased libido and sexual function.

26 d, age was the most important determinant of sexual function.

27 ive procedures to comment on their effect on sexual function.

28 84% of patients reported no change in sexual function.

29 land lipid production, as well as immune and sexual function.

30 voiding symptoms, related complications, and sexual function.

31 4R-controlled neuronal pathways that control sexual function.

32 or circuits involved in thermoregulation and sexual function.

33 nd etiological issues in the study of female sexual function.

34 ression of, or reduce, deformity and improve sexual function.

35 al/iatrogenic factors associated with female sexual function.

36 nd current literature on the neurobiology of sexual function.

37 IQR, 23 to 37; abnormal, > 11), and abnormal sexual function.

38 ed quality of life, menopausal symptoms, and sexual function.

39 RTME allows for preservation of urinary and sexual functions.

40 s modulates sensory, motor, nociceptive, and sexual functions.

41 eatment including genitourinary, rectal, and sexual functions.

42 ns for not discussing emotional, social, and sexual functioning.

43 sed register and phenotypic data on lifelong sexual functioning.

44 nd mental health), psychosocial distress and sexual functioning.

45 easures included the Derogatis Interview for Sexual Functioning.

46 nd memory, vitality, bodily pain, sleep, and sexual functioning.

47 effects that affect women's psychosocial and sexual functioning.

48 to 100, with higher scores reflecting worse sexual functioning.

49 Secondary outcomes were vaginal symptoms and sexual functioning.

50 ikely to have a moderate to big problem with sexual function (50.6% v 44.4%; P = .04).

51 ifference was defined as 10 to 12 points for sexual function, 6 for urinary incontinence, 5 for urina

52 ically important difference was 10 to 12 for sexual function, 6 to 9 for urinary incontinence, 5 to 7

53 self-ratings of problems with continence and sexual function a median of 14 months postoperatively.

54 ppears to serve several important social and sexual functions, a greater understanding of this form o

55 ation-based studies are needed to understand sexual function across the life course.

56 th Cancer provides recommendations to manage sexual function adverse effects that occur as a result o

57 lopment, hormonal regulation, fertility, and sexual function, affecting quality of life.

58 sthesis placement results in early return to sexual function after CaP treatment with high patient sa

59 successfully restoring cosmetic, urinary and sexual function after complete penile loss.

60 was to compare long-term urinary, bowel, and sexual function after radical prostatectomy or external-

61 ermal testosterone in women who had impaired sexual function after surgically induced menopause.

62 but little is known about sexual activity or sexual function after the event.

63 ast cancer survivors and its relationship to sexual functioning after cancer.

64 ontinence at > or =18 months [P = .03]), and sexual function also varied by race (38.4% of black men

65 Decreased sexual functioning among female survivors of childhood c

66 lude a process of adjusting one's concept of sexual function and activity through shifting to thought

67 recovery, and decline in urinary, bowel, and sexual function and associated quality of life differed

68 Sexual function and bother were also independently assoc

69 ted use of MDMA may result in impairments in sexual function and decreased sex drive in human users.

70 HCT recipients using Derogatis Interview for Sexual Function and Derogatis Global Sexual Satisfaction

71 er, mice treated with ASC-J9 retained normal sexual function and fertility.

72 e 74 patients who underwent RTME showed that sexual function and general sexual satisfaction decrease

73 tion have expanded our understanding of male sexual function and have allowed the development of new

74 artery calcium; secondary outcomes included sexual function and health-related quality of life.

75 ed up by questionnaires on urinary symptoms, sexual function and impact on quality of life, as well a

76 Menopause triggers changes in sexual function and many women develop sexual problems.

77 terectomy, transdermal testosterone improves sexual function and psychological well-being.

78 Multiple factors influence sexual function and reproductive health in this patient

79 were spontaneous erection at 1 year; overall sexual function and satisfaction; marital adjustment; an

80 Psychosexual development, sexual function and social adaptation have received as m

81 f age had a moderate benefit with respect to sexual function and some benefit with respect to mood an

82 d measures that assessed urinary, bowel, and sexual function and specific effects on quality of life,

83 se of T could be defined that would maintain sexual function and suppress gonadotropins without simul

84 esents the role of estrogen and androgens in sexual function and their potential roles as therapeutic

85 sity has been associated with impairments in sexual function and untoward changes in reproductive hor

86 atectomy had the greatest negative effect on sexual function and urinary continence, and although the

87 my was associated with a greater decrease in sexual function and urinary incontinence than either EBR

88 ne therapy may provide small improvements in sexual functioning and quality of life but little to no

89 Testosterone therapy improved sexual functioning and quality of life in men with low t

90 -based cognitive behavioral therapy (CBT) on sexual functioning and relationship intimacy (primary ou

91 ntimacy and relationship issues, and overall sexual functioning and satisfaction.

92 used to measure quality-of-life concepts of sexual functioning and social networks.

93 reported significant improvements in overall sexual functioning and specific domains of sexual functi

94 -induced ovarian suppression on mood, sleep, sexual function, and nighttime hot flushes.

95 involved in energy homeostasis, food intake, sexual function, and obesity.

96 ed age when conception is attempted, limited sexual function, and possibly medications limiting ovari

97 Secondary endpoints included fatigue, sexual function, and safety measures.

98 Endocrine disease frequently interrupts sexual function, and sexual dysfunction may signal serio

99 ying roles in modulating locomotor activity, sexual function, and the response to drugs of abuse.

100 al symptoms and problems with relationships, sexual functioning, and body image.

101 ales on menstrual and reproductive outcomes, sexual functioning, and dyadic adjustment.

102 on, or mania; impairment of reproductive and sexual function; and dermatological manifestations, main

103 Although compromised sexual function appears directly related to poor sleep i

104 ns, more specific comparisons of urinary and sexual function are conflicting and complicated by sex-s

105 Central nervous system influences on sexual function are discussed briefly with reference to

106 nervous system influences on male and female sexual function are discussed for sexual desire, arousal

107 Risks of problems with continence and sexual function are high after both procedures.

108 selection is less straightforward when both sexual functions are performed throughout the organism's

109 l sexual functioning and specific domains of sexual functioning: arousal, lubrication, desires, and s

110 nt groups experienced improvement in overall sexual function as well as in most individual measures.

111 resolution and satisfaction, body image, and sexual functioning, as well as other aspects of mental h

112 tal questionnaire, incorporating a validated sexual function assessment inventory.

113 fference, -10.9 [95% CI, -14.2 to -7.6]) and sexual function at 3 years (adjusted mean difference, -1

114 ce, -4.1 [95% CI, -6.3 to -1.9]), but better sexual function at 5 years (adjusted mean difference, 12

115 for unfavorable-risk disease reported worse sexual function at 5 years compared with men who underwe

116 low controls in rates of sexual activity and sexual function at 5 years.

117 e was a significant deterioration in overall sexual function at 6 months after surgery, with a partia

118 Therefore any effects on sexual function become even more important.

119 a recent study, with risk factors for poorer sexual functioning being age, treatment, time since trea

120 in men is associated with reduced levels of sexual function, bioactive testosterone and sperm.

121 n Internet-based CBT has salutary effects on sexual functioning, body image, and menopausal symptoms

122 entation is commonly used for its effects on sexual function, bone health and body composition, yet i

123 analysis included reporting moderate or big sexual function bother (reported by 39.0%; OR, 2.77; 95%

124 radiation has less impact on continence and sexual function but noteworthy bowel toxicity.

125 Men improved from their 6-month nadir in sexual function by 2 years (P = .02), whereas women did

126 We assessed the distribution of sexual function by use of a novel validated measure (the

127 al development, testosterone production, and sexual function, can be impaired by cancer therapy.

128 was score on the Clinical Global Impression-Sexual Function (CGI-SF); secondary measures were scores

129 eted to cancer, such as sleep/wake function, sexual function, cognitive function, and the psychosocia

130 prospect of a significantly lower impact on sexual function compared with standard surgical options.

131 sfunction in whom there is no improvement in sexual function (conditional recommendation; low-certain

132 with sexual dysfunction who want to improve sexual function (conditional recommendation; low-certain

133 icipants' global assessments, and indices of sexual function, continence, sleep quality, and prostati

134 Sexual function could be compromised by clitoral surgery

135 hat the genetic basis for the loss of female sexual function could be explained by a dominant nuclear

136 We assess factors associated with low sexual function (defined as the lowest quintile of distr

137 urgical treatments have different effects on sexual function depending on how much the internal invol

138 evere non-motor symptoms (including mood and sexual function), depressive symptoms, sleep impairment

139 t instruments were used to assess changes in sexual function, depressive symptoms, and quality of lif

140 ral oophorectomy, many women report impaired sexual functioning despite estrogen replacement.

141 sychological General Well-Being Index, and a sexual-function diary completed over the telephone.

142 Improvement in fatigue and sexual function did not differ between groups, nor did s

143 Sexual functioning did not differ significantly between

144 ing various disease states including cancer, sexual function disorders, Alzheimer's disease, social d

145 ivities in patients and with their partners; sexual function disturbances; and sexuality and cognitiv

146 All male sexual function domains declined after total body irradi

147 All sexual function domains were worse in women compared wit

148 mental sex determination (ESD) - a change in sexual function during an individual life span driven by

149 unctioning predicted the greatest decline in sexual function during Lupron plus placebo.

150 fen resulted in worse endocrine symptoms and sexual functioning during the first 2 years of treatment

151 aid to medical/health conditions that impact sexual function (e.g. neurological conditions, cancer, h

152 significant improvement over time in overall sexual functioning (effect size for T2 [EST2] = .43; P =

153 mediating testosterone's effects on muscle, sexual function, erythropoiesis, and other androgen-depe

154 ors in feeding behavior, energy homeostasis, sexual function, etc.

155 36-Item Short Form Health Survey) and female sexual function (Female Sexual Function Index) scores.

156 re the risks of problems with continence and sexual function following these procedures among Medicar

157 ignificant reduction of both overall QoL and sexual function for hypogonadal men.

158 d males or females will express the opposite sexual function for which their phenotypes have been opt

159 ty and pleasure-orgasm in the Brief index of Sexual Functioning for Women (P=0.03 for both comparison

160 asures included scores on the Brief Index of Sexual Functioning for Women, the Psychological General

161 e high, indicating good function, except for sexual function, for which scores were much lower.

162 sexes declined in sexual activity rates and sexual function from before HCT to 6 months afterward (P

163 No difference was noted in overall female sexual function from preoperatively to 1 and 3 months po

164 Male sexual function had not been completely lost, though som

165 ore specifically address urinary, bowel, and sexual function have been utilized to measure HRQOL foll

166 dian score, 14; IQR, 3 to 20; P < .001), and sexual function improved in all but one domain.

167 y of vessel-sparing radiotherapy to preserve sexual function in 90% of patients at the 5 year follow-

168 ed problems with individual sexual response, sexual function in a relationship context, and self-appr

169 th a sexually transmitted infection, and low sexual function in both sexes, and, in women, with abort

170 ies have shown the impact of radiotherapy on sexual function in cervical cancer and have highlighted

171 pies for lower urinary tract symptoms affect sexual function in men is important to both urologists a

172 initiating testosterone treatment to improve sexual function in men with age-related low testosterone

173 roved erectile function and other aspects of sexual function in men with sexual dysfunction associate

174 ndrosterone contributes to the regulation of sexual function in men.

175 Predictors of sexual function in ovarian cancer have been suggested by

176 evaluate the effect of radiotherapy (RT) on sexual function in patients undergoing oncologic resecti

177 ttle investigation of the effects of MDMA on sexual function in rodents.

178 , supporting calls for a greater emphasis on sexual function in sexual health policy and intervention

179 ve depression symptom severity, fatigue, and sexual function in small studies in women not formally d

180 the short term, repeated procedures may harm sexual function in the long-term.

181 on of pain processing, thermoregulation, and sexual function in the spinal cord.

182 es depression symptom severity, fatigue, and sexual function in women with antidepressant-resistant m

183 Sexual function in women with RA is hampered by pain and

184 after menopause does improve some aspects of sexual function in women, but long-term outcome data are

185 e findings were similar for other domains of sexual function in younger men, more obese men, and men

186 gery had significant improvements in overall sexual functioning, in most reproductive hormones of int

187 Many aspects of sexual function (including overall function, desire, org

188 red questionnaires concerning sexual desire, sexual function, including erectile and ejaculatory func

189 esigned a peer counseling program to improve sexual function, increase knowledge about reproductive h

190 biopsies, MRIs, and self-administered Female Sexual Function Index questionnaire results for all pati

191 A validated self-administered Female Sexual Function Index questionnaire showed variables in

192 d evaluated sexual function using the Female Sexual Function Index scores for arousal and vaginal lub

193 h Survey) and female sexual function (Female Sexual Function Index) scores.

194 ional Index of Erectile Function, and Female Sexual Function Index), and oncological outcomes.

195 nd 12 months after surgery, using the Female Sexual Function Index, Rosenberg Self-Esteem scale, Body

196 unctioning was assessed by use of the Female Sexual Function Index.

197 female version, the University of New Mexico Sexual Function Inventory-female version, a sexual activ

198 dysfunction was assessed with the Brief Male Sexual Function Inventory.

199 Low sexual function is associated with negative sexual healt

200 The effect of diabetes on women's sexual function is complex: the most consistent finding

201 s importance to sexual health and wellbeing, sexual function is given little attention in sexual heal

202 Healthy sexual function is important to maintain a good quality

203 Men's satisfaction and sexual function is influenced by discomfort over genital

204 e restorative procedures are discouraged and sexual function is no longer desired, obliterative proce

205 Sexual function is the health-related quality of life (H

206 In our experience to date, female sexual function is unchanged and quality of life either

207 survival and quality of life--fertility and sexual function--is of significant concern to patients a

208 Despite the brain's central role in sexual function, little is known about relationships bet

209 c stroke in brain areas contributing to male sexual function may impair erectile function depending o

210 61.5 years, P < .001) and had worse baseline sexual function (mean score, 52.3 vs 65.2, P < .001) tha

211 nces, survivors reported significantly lower sexual functioning (mean difference [MnD], -0.2; P = .01

212 at 3-month follow-up assessed spirituality, sexual function, menopause symptoms, emotional distress,

213 The assessment and treatment of sexual functioning must become part of the standard care

214 eeks and who had reported a deterioration in sexual function not present before the initiation of flu

215 alone can expect overall quality of life and sexual function not unlike that of peers without a histo

216 ttle is known about the sexual behaviors and sexual function of older people.

217 The effects on sexual function of surgical removal of parts of the clit

218 ns for benign prostatic hyperplasia (BPH) on sexual function or dysfunction?

219 ry artery calcium nor did it improve overall sexual function or health-related quality of life.

220 There were no reported changes in sexual function or menstruation after donation, and five

221 does not appear to negatively affect female sexual function or quality of life in the short term.

222 sociated with significantly improved overall sexual function or satisfaction; a significant differenc

223 al factors are significantly associated with sexual functioning or satisfaction, sexual discomfort, a

224 as not associated with greater problems with sexual function (OR, 0.87; 95% CI, 0.51 to 1.49).

225 Long-term sexual function outcome data are essential for full eval

226 Sexual function outcomes were similar by treatment group

227 crocolpopexy (ASC) has improved anatomic and sexual functioning outcomes compared with the sacrospino

228 active across time (P < .001) and in overall sexual function (P < .001).

229 Superiority of IAD for sexual function, physical activity, and general well-bei

230 Questionnaires mailed in 2000 asked about sexual function, physical activity, body weight, smoking

231 erone level less than 275 ng/mL and impaired sexual function, physical function, or vitality were all

232 elopment and Evaluation) system and included sexual function, physical function, quality of life, ene

233 homeostasis, feeding behavior, inflammation, sexual function, pigmentation, and exocrine gland functi

234 ten affect adherence to medical therapy, and sexual function plays a major part in adolescence and yo

235 Older age negatively impacted sexual function post-HCT in both sexes (P < .01).

236 There is, however, a significant decline in sexual function postoperatively.

237 High baseline levels of sexual functioning predicted the greatest decline in sex

238 women were less likely than men to report no sexual function problems in the year after the event (46

239 Studies have identified sexual function problems in women and men with SSc.

240 vance: Impaired sexual activity and incident sexual function problems were prevalent and more common

241 comes: changes in fat mass, muscle strength, sexual function, prostate volume, sebum production, and

242 Changes in fat mass, muscle strength, sexual function, prostate volume, sebum production, and

243 y outcomes), sleep quality, HF/NS frequency, sexual functioning, psychological distress, and health-r

244 usal symptoms (primary outcome), body image, sexual functioning, psychological well-being, and health

245 ale Sexual Distress Scale), sexual function (Sexual Function Questionnaire), and resumption of interc

246 Secondary measures included the Female Sexual Function Questionnaire, the Arizona Sexual Experi

247 rience Scale, Massachusetts General Hospital-Sexual Functioning Questionnaire, and Hamilton Rating Sc

248 ransplantation (HCT) for cancer to determine sexual function recovery and residual problems.

249 The disparity in sexual function remained significant in a multivariate a

250 s of physical, daily, emotional, social, and sexual functioning, respectively.

251 nal score) on the Clinical Global Impression sexual function scale.

252 ey items included the Medical Outcomes Study Sexual Functioning Scale, satisfaction with sex life, fe

253 The scores for two sexual functioning scales could range from 0 to 100, wit

254 There was a trend to deterioration in sexual function score (mean decrease, 4.4 points; P = .0

255 Declines of 28.9% in the sexual function score and 5.4% in the bowel function sco

256 ontinued resulted in a mean end point in the sexual function score of 1.5 (95% CI, 1.1-1.9) among wom

257 enafil had a mean Clinical Global Impression-sexual function score of 1.9 (95% confidence interval [C

258 , African-Americans had significantly higher sexual function scores than non-Hispanic whites (43.9 v

259 Sexual desire, erectile function, overall sexual function scores, partner intimacy, and health-rel

260 de variability exists in the distribution of sexual function scores.

261 cant improvements in Derogatis Interview for Sexual Functioning scores relative to baseline and place

262 Sexual function, self-esteem, body image, and general he

263 ual distress (Female Sexual Distress Scale), sexual function (Sexual Function Questionnaire), and res

264 on FACT-P (P = .01) and decreased three-item sexual function subset (P = .003).

265 icance, despite reporting more problems with sexual function than non-Hispanic whites.

266 urvivors treated with radiotherapy had worse sexual functioning than did those treated with radical h

267 Radiotherapy has an adverse effect on sexual function, the effect being maximal at 8 months af

268 exual function was greatest at 6 months, but sexual function then recovered somewhat and was stable t

269 This prospective study evaluated sexual function through 5 years after myeloablative allo

270 icipated in one or more of three trials--the Sexual Function Trial, the Physical Function Trial, and

271 assessed their medical history and evaluated sexual function using the Female Sexual Function Index s

272 made of anxiety, psychological distress, and sexual functioning using standardized questionnaires bef

273 maintain lean mass, fat mass, strength, and sexual function varied widely in men.

274 Low sexual function was also associated with experiencing th

275 Low sexual function was also associated with negative sexual

276 tely lost, though some deterioration of male sexual function was also evident when males from the inf

277 International Prostate Symptom Score (IPSS); sexual function was assessed by 5-item version of the In

278 For men and women, low sexual function was associated with increased age, and,

279 Sexual function was better in the LL group compared to H

280 Poor sexual function was common (81.0%; 95% CI 80.6-81.5), re

281 The negative effect of radiotherapy on sexual function was greatest at 6 months, but sexual fun

282 Low sexual function was most common among women of white oth

283 A significant variability in sexual function was present among the 7 time points with

284 Sexual function was reported to be better and worse with

285 Sexual function was slightly better for participants ass

286 Sexual function was the most adversely affected quality-

287 timated 38%-48% of men reported that overall sexual function was worse than before treatment.

288 Sexual functioning was assessed by use of the Female Sex

289 ems (physical, daily, emotional, social, and sexual functioning) was examined among 374 NHL survivors

290 t areas, thigh-muscle area and strength, and sexual function were also assessed.

291 Urinary function and sexual function were also assessed.

292 Adverse effects of prostatectomy on sexual function were mitigated by nerve-sparing procedur

293 amined region, and (6). all five measures of sexual function were significantly correlated with ERK2

294 ion over time, changes in anxiety, mood, and sexual functioning were not associated with treatment gr

295 uality of life issues regarding visceral and sexual function when performing a rectocele repair.

296 There is a mixed impact on pelvic pain and sexual function which requires careful consideration in

297 d 5-hydroxytryptamine 1A receptors in female sexual function, while recent data suggest a role for th

298 ials observed an improvement in physical and sexual functioning with intermittent therapy.

299 of gynecological cancer and its treatment on sexual functioning, with information being provided abou

300 sleep, pain, pruritus, body image distress, sexual function, work disability, healthcare needs, psyc